bioAffinity Technologies gets Hong Kong patent for CyPath lung diagnostic
bioAffinity Technologies said Hong Kong’s Intellectual Property Department granted a patent covering its proprietary CyPath® noninvasive lung cancer diagnostic.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.